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Summary.-The antitumour effects of ICRF-159 and related analogues were evalua-
ted using the B16 melanoma. Treatment of mice with ICRF-159 inhibited tumour
growth, while each of the analogues, trans-4,41-(1,2-cyclopropandiyl) bis (2,6-piper-
azinedione) (trans-5), and cis-4,41-(1,2-cyclopropandiyl) bis (2,6-piperazinedione)
(cis-7) independently accelerated primary tumour growth. Pretreatment of B16
melanoma cultures either with ICRF-159 or the analogue cis-7 decreased the yield of
lung-colonies following i.v. injection of tumour cells. In contrast, pretreatment of
tumour cells with the trans-5 analogue led to an increase in lung colonies. The
effect on colonyformation in vitro ofthese analogues correlated with increased growth
in vivo, and not with lung colony formation.
PREVIOUS REPORTS from these labora-
tories have shown that ICRF-159 and
analogue trans-5 stimulated the growth
of a hamster adenocarcinoma of the lung,
whereas ICRF-159 and Analogue cis-7
had no effect on primary tumour growth.
The results also suggested that Analogue
cis-7 reduced metastasis of this tumour
model whilst trans-5 stimulated it (Witiak
et al., 1978). Since ICRF-159 is active
against a variety of tumours (Adamson,
1975; Atherton, 1975), and has been
reported to inhibit metastasis to the lung
of subcutaneously growing Lewis lung
carcinoma (LeServe & Hellmann, 1972;
Salsbury et al., 1970), this stereochemical
effect on tumour growth and metastasis is
particularly significant. As a prerequisite
to mechanism studies we have re-examined
the activity ofthese compounds, using the
syngeneic B16-Fl and F10 melanoma in
C57BL/6 mice (Fidler & Nicholson, 1976).
Furthermore, certain synthetic open-chain
and cyclic-analogue intermediates (for
structures of Compounds 1-7 see Fig. 1)
were studied to throw light on the speci-
ficity ofthe apparent stereoselective effect.
The results described in this article are
compared to those previously reported by
Lazo et al. (1978), who observed that
ICRF-159 treatment of B16 melanoma
cells in culture significantly increased
their lung-colony formation in vivo.
MATERIALS AND METHODS
Animals.-Male, C57BL/6J mice were ob-
tained from the Jackson Laboratory, Bar
Harbor,Maine, when 5 weeks old. The animals
were housed 20 per cage and given food and
water ad libitum. Mice were used when 8-12
weeks of age.
Tumours. The B16-Fl and B16-FIO mela-
noma tumour cells were kindly provided by
Dr Isiah J. Fidler. The B16-F1 cell line forms
few lung colonies when injected i.v., whereas
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COMPOUND
RIO~~~~
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rCRF-159, RzN NH, R'-Me
0
EDTA, R=N(CH2CO2H)2, R'=H
1, R=N(CH2CO2H)2, R'=Me
2, R=N(CH2CO2Me)2 (2*HCI), R'=Me
H R
L.N (trons)
RH
3, R=N(CH2CQ2H)2
4, R=N(CH2CO2Me)2 (2*CH1)
5,
0
R N NH
0
6, (trons)
-6, R=N(CH2C02H)2
7,
H (cis)
RENH
SOLVENT
0-4N Aqueous HCI
0-9% Saline solution
5% Aqueous NaHCO3
MeOH
5% Aqueous NaHCO3
MeOH
DMSO
5% Aqueous NaHCO3
30% Aqueous NA2CO3
Fia. 1. ICRF-159-related structures and stock solution solvents.
the B16-F10 cell line forms numerous lung
colonies (Fidler & Nicolson, 1976). The
tumour cells were maintained in complete
Eagle's Minimum Essential Medium, as
described by Fidler & Nicolson (1976).
Effect on tumour growth in vivo.-The anti-
tumour activities of ICRF-159 and the cis
andtransanalogues (7 and5) weredetermined
by monitoring the growth of an intradermal
injection of 105 B16-F10 tumour cells. The
greatest and least diameters were determined
using calipers and the tumour area is ex-
pressed in mm2. The animals received 30 mg/
kg of the cis or trans isomer as well as
ICRF-159, each mixed with 0.5% carboxy-
methyl cellulose (CMC). The slurry was
injected daily by the i.p. route.
Drug treatment.-To determine the effect
of the ICRF-159 analogues on lung-colony
formation in vivo and in vitro, cells were pre-
treated for 24 h with 2, 20 or 100 uM of the
compounds in culture medium. The ICRF-159
analogues, as well as the solvent used in the
preparation of stock solutions, are listed in
Fig. 1. Since compounds were not all soluble
in the same solvent, solvent controls were
always included and are expressed as zero
concentration in the data. To determine the
effect of various analogues on cell viability
the compounds were co-cultured for 3 days
with the melanoma tumour cells that had
been previously labelled with tritiated thy-
midine (Zwilling et al., 1975), [3H]dT,( 5,uCi/
ml, sp. act. 6f7 Ci/,umol, New England
Nuclear). The release oflabel was taken as an
indication of cell death, and the data are
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expressed as percentage of viable cells calcu-
lated by the following formula:
100(ct/min released 100 1 total ct/min
In vivo and in vitro colonyformation.- To
assess the ability of the tumour cells to form
lung colonies, mice were injected i.v. with
5 x 104 tumour cells in 0-2 ml, via the tail vein.
After 20 days the animals were killed, the
lungs removed and the number of black
nodules enumerated using a dissecting micro-
scope.
To determine colony formation in vitro 102
cells were placed in a 60mm culture dish
containing complete medium. The cells were
cultured for 7-10 days in a humidified atmo-
sphere containing 500 CO2. The colonies
formed by individual cells wA-ere counted.
RESULTS
Effect of tumour cell growth
Injection of the cis and trans isomers
into tumour-bearing animals accelerated
the tumour growth (Fig. 2). Palpable
tumours were detected as early as 6 days
after implantation, and grew to a size of
100-250 mm2 after 22 days. In contrast,
tumours from animals injected with ICRF-
159 did not appear until the 17th day, and
were only 30 mm2 in size after 22 days.
Tumours from animals treated with saline
or CMC appeared 12-15 days after implan-
tation, and reached 60-80 mm2 by Day 22.
The animals were killed on Day 22 and
the lungs were examined for metastases.
None were found.
Effect on colony formation in vivo and in
vitro
Treatment of tumour cells with ICRF-
159-related analogues did not affect the
viability of the tumour cells, even after
3 days' co-cultivation (Table I).
TABLE I.-Effect ofICRF-related analogues
on the °0 viability ofBl6-F1I0 melanoma*
300
E ~ ~~TM goys
so i-7 anlIR-150n2lowrgol.
60 j (12
30
20
to 1
5 10 .1$ 20. 25
TIME.(days)
FiG. 2.-Effect of sterceoisomers trans-5 andi
eis-7 andi ICRF- 159 on tuimouir growth.
(CAIC =carboxymethyl celltlose.) Animals
-were inoculated witlh 105 tuimour cells.
OIe (lay later they receive daily i.p.
injections of the compounds until termina-
tion of the experiment. The numbers in
parentheses indicate t,he number of animals
with tuimotur over the3 ntumber injecte(l.
D)ose
Solvent
2
20
100
5
31t
92
91*2
89
Comrnound
7 I(RF-159
90 5
91-5
91-1
76-2
92-2
92 3
9(09
91*1
* Tumour cells that we-re prelabelledl witlh [3H]IdT
wAere inicubate(d witlh compoundls for 72 h.
t Quantitative data are always confirmed by
visual inspection of the cultures before termination.
The Kruskal-Wallis nonparametric one-
way layout was used to determine whether
differences existed between the solvent
control and any of the 3 concentrations of
each compound (Hollander & Wulfe,
1973). This test was selected in preference
to its parametric analogues on account of
the relatively small number of animals per
group (10) and possible non-normalities
in the distribution of metastases. Where
significant differences were detected among
the 4 groups, pairwise tests were computed
according to the method ofDunn (1964).
The stereoisomeric analogues of ICRF-
159 had opposing effects on the ability of
the B16 melanoma to form lung colonies.
When cultures ofthe B16-Fl0 cell linewere
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TABLE II.-Effect of pretreatment with trans-5 and cis-7 analogues of ICRF-159 on
in vivo and in vitro colonyformation of the B16-F10 melanoma
Compound (pM)
Trans-5
Cis-7
ICRF-159
Median lung colonies
r
A
0 2 20
167 229 197
125 53 110
117 57 76
Median in vitro colonies
100 0
85 54
169 30
83 36
2
104
36
9
20 100
82
56
17
TABLE III.-Effect of pretreatment with trans-5 and cis-7 analogues of ICRF-159 on
in vivo and in vitro colonyformation of the B16-Fl melanoma
Median lung colonies
Compound (zM)
Trans-5
Cis-7
ICRF-159
0
8
5
1
2
3
1
3
20
2
3
4
pretreated with trans-5 at concentrations
of 2 and 20 ,uM, an increase in lung colony
formation (P < 0-001) was noted (Table
II). In contrast, pretreatment of the
melanoma cells with the cis-7 isomer
reduced lung-colony formation (P < 0'001).
The effect ofICRF-159 was similar to that
ofthe cis isomer. Results for colony forma-
tion in vitro paralleled those obtained in
vivo, except for the cis isomer. Whilst lung-
colony formation was inhibited by the cis
isomer, colony formation in vitro was
stimulated (P< 0 05 at 20 and 100 ,uM).
Whereas the F10 cell line of the B16
melanoma forms lung colonies after i.v.
injection, the Fl cell line forms few (Fidler
& Nicolson, 1976). It was of interest,
therefore, to determine whetherthe stereo-
isomers of ICRF-159 could affect the
colony-forming potential of the Fl cell
line. The results in Table III indicate that
neither the cis nor the trans isomers had
100
3
3
1
Median in vitro colonies
/ ~ ~~~
0 2 20 100
43 53 29 31
62 59 48 27
57 16 3 3
an effect on lung-colony formation of the
Fl cell line. Although the Kruskal-Wallis
test was significant at P< 0 05, pairwise
comparisons failed to show a strong
colony-forming effect.
Zwitterionic acids (EDTA, 1, 3, and 6)
had variable effects on the median number
of lung colonies from B16-F10 tumour
cells (Table IV). Thus cyclobutyl analogue
6 exhibited no significant effect, and open-
chain isomer 1 significantly increased
colony formation, while EDTA and trans-
cyclopropyl analogue 3 significantly
decreased lung colonies. Ester-HCl salts
2 and 4 also decreased lung-colony
formation according to Kruskal-Wallis
tests. However, even though significant
Kruskal-Wallis tests were obtained for
Compounds 1, 3 and 4, the pair-wise
comparisons did not reveal a strong
or consistent pattern of lung-colony in-
hibition. Only open-chain analogue 2 at
TABLE IV.-Effect of ICRF-159-related analogues (1-6) on lung-colony formation of
B16-F10 melanoma
Median number of lung colonies greated with:
K o~~~~~~
1
53
14-5
40
< 0-001
2 3 4 6 EDTA*
16 6*5 35-5 19-5 4
5.5 4 48 52 6
26-5 19 42-5 22 1
< 0-05 < 0-01 < 0.01 N.S. < 0 001
* Median number for saline-treated control = 13.
39
64
55
10
Dose
(4M)
2
20
100
p
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20 /LM (P < 0.05) or EDTA at 2 and
100 HM (P < 0.05) had significant inhibitory
effects.
DISCUSSION
The aim of cancer therapy is to reduce
or eliminate the primary tumour burden,
and to prevent metastases and growth of
tumour cells away from the primary
tumour. The anticancer drug ICRF-159
has been reported to inhibit primary
tumour growth (Adamson, 1975) and to
prevent metastasis of the Lewis lung
carcinoma (LeServe & Hellman, 1972;
Salsbury et al., 1970). The inhibition of
metastasis was seen at doses that did not
effect the growth of the primary tumour.
LeServe & Hellman (1972) and James &
Salsbury (1974) reported that the anti-
metastatic effect was due to changes in the
tumour vasculature, which prevented the
entry ofthe Lewis lung carcinoma into the
circulation.
We had previously reported the syn-
thesis of stereoisomeric analogues (cis-7
and trans-5) of ICRF-159 and in a pre-
liminary study we indicated that the cis
isomer had a marginal antimetastatic
effect, while the trans isomer appeared to
stimulate metastasis (Witiak et al., 1978).
The current investigation supports and
reinforces those initial observations. Pre-
treatment of the tumour cells with low
doses of the cis isomer inhibited the lung-
colony formation of the B16 melanoma,
while similar doses of the trans isomer
stimulated metastasis. Furthermore, little
or no effect was found for various synthetic
intermediate zwitterionic or ester-HCl
salts (Table IV), suggesting that the
bisdiketopiperazine functions play an im-
portant role in the stereoselective process.
It is not known what part, if any, solu-
bility differences between trans-5 and cis-7
play in these observations. It was difficult
to completely solubilize the 1OOVM con-
centration of both compounds which may
account for the variable effects at this
concentration. Further studies will evalu-
ate the effect oflower doses.
In some cases our results with ICRF-159
seemed similar to those reported by Lazo
et al. (1978). Pretreatment of B16 mela-
noma cells with 20 tM ICRF-159 produced
more lung colonies than cells pretreated
with 2 HM. Our study, however, indicated
that ICRF-159 inhibited lung colony
formation at 2 HM and 100/iM, andthatthis
effect paralleled colony inhibition in vitro.
In contrast Lazo et al. (1978) reported
that the colony formation in vivo was
stimulated by pretreatment with ICRF-
159 at 20 and 100 ,tM, while formation in
vitro was inhibited. Lazo et al. (1978),
however, failed to obtain 100% lung-
colony formation in control mice, and
expressed their data only in terms of mice
with lung colonies. They obtained 8 7
lung colonies per mouse in untreated
animals. Using similar numbers of tumour
cells we obtained 50-150 lung colonies
per mouse, a level consistent with that
reported by Fidler & Nicolson (1976).
Since ICRF-159 can be visualized as the
propyl analogue diketopiperazine ofEDTA
(Fig. 1) we chose to remove the tumour
cells in the absence of EDTA, by gently
scraping the cells from the monolayer.
Tumour cells used by Lazo et al. (1978)
were removed by treatment with EDTA.
This may account for the decreased lung-
colony formation. EDTA-treated tumour
cells yielded significant decreases in lung-
colony formation at 2 pM and 100ftM con-
centrations in our studies.
Our results indicate that ICRF-159 and
the cis isomer may inhibit metastasis by a
mechanism independent of its angiometa-
morphic effect (James & Salsbury, 1974;
LeServe & Hellman, 1972; Salsbury et al.,
1974). When tumour cells were pretreated
with drug, no primary tumour was estab-
lished. While the compounds were not
toxic for the tumour cells, they did affect
colony formation in vitro. This effect did
not correlate with the lung-colony forma-
tion. Colony formation in vitro, which was
stimulated by both the cis and trans
isomers, seemed to correlate with the
accelerated growth rates of the tumours
in animals injected with these compounds.
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